Skip to main content

CCTG at ASCO GI 2023

The ASCO Gastrointestinal Cancers Symposium was held last weekend January 19-21, 2023 in Moscone West, San Francisco, CA. CCTG support some great trial results and posters. Pictured above is Dr Solar Vasconcelos who was honoured with a merit award for his poster at #GI23 on Predictive & prognostic features of metastatic colorectal cancer arising from the transverse colon: a pooled analysis of the CCTG CO17/CO20 trials with Dr Jonathan Loree and Senior Investigator Chis O'Callaghan.

CCTG HE.1

Canadian Cancer Trials Group HE.1: A phase III study of palliative radiotherapy for symptomatic hepatocellular carcinoma and liver metastases

Session Type:        Oral Presentation

Session Title:         Rapid Abstract Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Citation:                  JCO 2023 TBD

Abstract #:              LBA492

Authors:                  Laura Dawson, Alysa Fairchild, Kristopher Dennis, Aamer Mahmud, Teri Stuckless, Francois Vincent, David Roberge, Matthew Follwell, Raimond Wong, Derek Jonker, Jennifer Knox, Camilla Zimmermann, Philip Wong, Tom Purdie, Jolie Ringash, Aisling Barry, Marc Gaudet, Dongsheng Tu, Rebecca Wong, Christopher O'Callaghan

Abstract link:         https://meetings.asco.org/abstracts-presentations/215519

CCTG GA.3/AGITG INTEGRATE IIa

INTEGRATE IIa: A randomised, double-blind, phase III study of regorafenib versus placebo in refractory advanced gastro-oesophageal cancer (AGOC)—A study led by the Australasian Gastro-intestinal Trials Group (AGITG)

Session Type:        Poster Session

Session Title:         Poster Session A: Cancers of the Esophagus and Stomach and Other GI Cancers

Citation:                  JCO 2023 TBD

Abstract #:              LBA294

Authors:                  Nick Pavlakis, Kohei Shitara, Katrin Sjoquist, Andrew Martin, Anthony Jaworski, Sonia Yip, Yung-Jue Bang, Thierry Alcindor, Christopher O'Callaghan, Niall Tebbutt, Andrew Strickland, Sun Rha, Keun-Wook Lee, John Zalcberg, Timothy Price, John Simes, David Goldstein

Abstract link:         https://meetings.asco.org/abstracts-presentations/216504

CCTG CO.26

Plasma phosphocreatine (PC) as a predictive biomarker for immune checkpoint inhibition in patients with refractory metastatic colorectal cancer (mCRC): Analysis of the CCTG CO.26 trial

Session Type:        Poster Session

Session Title:         Poster Session C: Cancers of the Colon, Rectum, and Anus

Citation:                  JCO 2023 TBD

Abstract #:              183

Authors:                  Lucy Ma, Jonathan Loree, Derek Jonker, Hagen Kennecke, Scott Berry, Felix Couture, Chaudhary Ahmad, John Goffin, Petr Kavan, Mohammed Harb, Bruce Colwell, Setareh Samimi, Benoit Samson, Tahir Abbas, Nathalie Aucoin, Francine Aubin, Sheryl Koski, Dongsheng Tu, Christopher O'Callaghan, Eric Chen

Abstract link:         https://meetings.asco.org/abstracts-presentations/215839

CCTG CO.28

Feasibility of circulating tumor DNA (ctDNA) to guide organ preservation in patients with node-negative rectal cancer undergoing neoadjuvant chemotherapy, excision, and observation in the phase II CCTG CO.28 trial

Session Type:        Poster Session

Session Title:         Poster Session C: Cancers of the Colon, Rectum, and Anus

Citation:                  JCO 2023 TBD

Abstract #:              180

Authors:                  Jonathan Loree, Russell Madison, Christopher O'Callaghan, Carl Brown, Dongsheng Tu, Derek Jonker, Max Sherry, Alexander Fine, Yanmei Huang, William Camara, Prapti Pokharel, Alexey Aleshin, Geoffrey Oxnard, Hagen Kennecke

Abstract link:         https://meetings.asco.org/abstracts-presentations/215979

CCTG CO.17/CO.20

Pictured above Dr Solar Vasconcelos who was honoured with a merit award for his poster at #GI23 Predictive & prognostic features of metastatic colorectal cancer arising from the transverse colon: a pooled analysis of the CCTG CO17/CO20 trials with Dr Jonathan Loree Senior Investigator Chis O'Callaghan

Predictive and prognostic features of metastatic colorectal cancer arising from the transverse colon: A pooled analysis of the CCTG/AGITG CO.17 and CO.20 randomized trials

Session Type:        Poster Session

Session Title:         Poster Session C: Cancers of the Colon, Rectum, and Anus

Citation:                  JCO 2023 TBD

Abstract #:              124

Authors:                  Joao Paulo Solar Vasconcelos, Nan Chen, Dongsheng Tu, Stephanie Brule, Rachel Goodwin, Derek Jonker, Timothy Price, John Zalcberg, Malcolm Moore, Christos Karapetis, Lillian Siu, Jeremy Shapiro, John Simes, Christopher O'Callaghan, Jonathan Loree

Abstract link:         https://meetings.asco.org/abstracts-presentations/215974

CCTG CRC.10/NRG GI008

NRG GI008: Colon adjuvant chemotherapy based on evaluation of residual disease (CIRCULATE-US)

Session Type:        Trials in Progress Poster Session

Session Title:         Trials in Progress Poster Session C: Cancers of the Colon, Rectum, and Anus

Citation:                  JCO 2023 TBD

Abstract #:              TPS260

Authors:                  Christopher Lieu, Yan Lin, Scott Kopetz, Samuel Jacobs, Peter Lucas, Ibrahim Sahin, Dustin Deming, Philip Philip, Theodore Hong, Yesenia Rojas-Khalil, Jonathan Loree, Norman Wolmark, Greg Yothers, Thomas George, Arvind Dasari

Abstract link:         https://meetings.asco.org/abstracts-presentations/216082

CCTG CRC.9/NRG GI005

Phase II/III study of circulating tumor DNA as a predictive biomarker in adjuvant chemotherapy in patients with stage II colon cancer: NRG-GI005 (COBRA)

Session Type:        Trials in Progress Poster Session

Session Title:         Trials in Progress Poster Session C: Cancers of the Colon, Rectum, and Anus

Citation:                  JCO 2023 TBD

Abstract #:              TPS259

Authors:                  Van Morris, Greg Yothers, Scott Kopetz, Samuel Jacobs, Peter Lucas, Atif Iqbal, Patrick Boland, Dustin Deming, Aaron Scott, Howard Lim, Theodore Hong, Norman Wolmark, Thomas George

Abstract link:         https://meetings.asco.org/abstracts-presentations/216058